Therapeutic, Humanized Monoclonal Antibody Exhibits Broad Binding and Protective Efficacy against Acinetobacter baumannii

被引：5
|
作者：
Slarve, Matthew [1 ]
Reyna, Zeferino [1 ]
Burk, Elizabeth [1 ]
Ruiz-Delgado, Juan [1 ]
Li, Rachel [1 ]
Yan, Jun [1 ]
Luna, Brian [1 ]
Spellberg, Brad [2 ]
机构：
[1] Keck Sch Med USC, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA
[2] Angeles Cty USC LACUSC Med Ctr, Los Angeles, CA USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2023年 / 67卷 / 03期
关键词：
Acinetobacter baumannii; K antigen; monoclonal antibody; O antigen; antibiotic resistance; carbohydrates; therapeutic;
D O I：
10.1128/aac.00086-23
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Acinetobacter baumannii is an extremely drug-resistant pathogen necessitating the development of new therapies. We seek to generate a cocktail of monoclonal antibodies (MAbs) that can target the full diversity of A. baumannii isolates. We have newly identified the antibody MAb5. Here, we demonstrate that MAb5 has broad binding against U.S. (n = 300) and international (n = 250) isolates (72.24% and 28.76%, respectively), likely targets O-antigen capsular carbohydrates, and exhibits protective efficacy in vivo. Acinetobacter baumannii is an extremely drug-resistant pathogen necessitating the development of new therapies. We seek to generate a cocktail of monoclonal antibodies (MAbs) that can target the full diversity of A. baumannii isolates.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Monoclonal Antibody Therapy against Acinetobacter baumannii
    Nielsen, Travis B.
    Yan, Jun
    Slarve, Matthew
    Lu, Peggy
    Li, Rachel
    Ruiz, Juan
    Lee, Bosul
    Burk, Elizabeth
    Talyansky, Yuli
    Oelschlaeger, Peter
    Hurth, Kyle
    Win, William
    Luna, Brian M.
    Bonomo, Robert A.
    Spellberg, Brad
    INFECTION AND IMMUNITY, 2021, 89 (10)
  • [2] Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection
    Nielsen, Travis B.
    Yan, Jun
    Luna, Brian M.
    Talyansky, Yuli
    Slarve, Matthew
    Bonomo, Robert A.
    Spellberg, Brad
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (12) : 2133 - 2147
  • [3] Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
    Nielsen, Travis B.
    Pantapalangkoor, Paul
    Luna, Brian M.
    Bruhn, Kevin W.
    Yan, Jun
    Dekitani, Ken
    Hsieh, Sarah
    Yeshoua, Brandon
    Pascual, Bryan
    Vinogradov, Evgeny
    Hujer, Kristine M.
    Domitrovic, T. Nicholas
    Bonomo, Robert A.
    Russo, Thomas A.
    Lesczcyniecka, Magda
    Schneider, Thomas
    Spellberg, Brad
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (04) : 489 - 501
  • [4] Protective Capacity of Monoclonal Antibodies against Acinetobacter baumannii K9 Capsular Polysaccharide
    Karatovskaya, Anna
    Rudenko, Natalia
    Zamyatina, Anna
    Zvonarev, Anton
    Oleinikov, Vladimir
    Shpirt, Anna
    Perepelov, Andrei
    Knirel, Yuriy
    Brovko, Fedor
    MICROBIOLOGY SPECTRUM, 2023, 11 (01):
  • [5] Protective potentials of a siderophore receptor against Acinetobacter baumannii infections
    Aghajani, Zahra
    Rasooli, Iraj
    Gargari, Seyed Latif Mousavi
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2019, 9 (04): : 3987 - 3995
  • [6] Osmotic Compounds Enhance Antibiotic Efficacy against Acinetobacter baumannii Biofilm Communities
    Falghoush, Azeza
    Beyenal, Haluk
    Besser, Thomas E.
    Omsland, Anders
    Call, Douglas R.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2017, 83 (19)
  • [7] Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy
    Resa-Infante, Patricia
    Erkizia, Itziar
    Muniz-Trabudua, Xabier
    Linty, Federica
    Bentlage, Arthur E. H.
    Perez-Zsolt, Daniel
    Munoz-Basagoiti, Jordana
    Raich-Regue, Dalia
    Izquierdo-Useros, Nuria
    Rispens, Theo
    Vidarsson, Gestur
    Martinez-Picado, Javier
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [8] Discovery of GuaB inhibitors with efficacy against Acinetobacter baumannii infection
    Kofoed, Eric M.
    Aliagas, Ignacio
    Crawford, Terry
    Mao, Jialin
    Harris, Seth F.
    Xu, Min
    Wang, Shumei
    Wu, Ping
    Ma, Fang
    Clark, Kevin
    Sims, Jessica
    Xu, Yiming
    Peng, Yutian
    Skippington, Elizabeth
    Yang, Ying
    Reeder, Janina
    Ubhayakar, Savita
    Baumgardner, Matt
    Yan, Zhengyin
    Chen, Jacob
    Park, Summer
    Zhang, Hua
    Yen, Chun-Wan
    Lorenzo, Maria
    Skelton, Nicholas
    Liang, Xiaorong
    Chen, Liuxi
    Hoag, Bridget
    Li, Chun Sing
    Liu, Zhiguo
    Wai, John
    Liu, Xingrong
    Liang, Jun
    Tan, Man Wah
    MBIO, 2024, 15 (10)
  • [9] Evaluation the reactivity of a peptide-based monoclonal antibody derived from OmpA with drug resistant pulsotypes of Acinetobacter baumannii as a potential therapeutic approach
    Yeganeh, Omid
    Shabani, Mahdi
    Pakzad, Parviz
    Mosaffa, Nariman
    Hashemi, Ali
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2022, 21 (01)
  • [10] An Update on the Therapeutic Potential of Antimicrobial Peptides against Acinetobacter baumannii Infections
    Rangel, Karyne
    Lechuga, Guilherme Curty
    Provance Jr, David W.
    Morel, Carlos M.
    De Simone, Salvatore G.
    PHARMACEUTICALS, 2023, 16 (09)
12345